Clinical Trial Update: Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating concurrent transarterial chemoembolization (TACE) and sorafenib for hepatocellular carcinoma with metastasis; efficacy and saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Metastasis

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Asan Medical Center | Conditions: Hepatocellular Carcinoma, Metastasis | Phase 2 | Status: UNKNOWN